HomeGreater Than Icon
Mutual FundsGreater Than Icon
Compare Mutual FundsGreater Than Icon
ICICI Pru Technology Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

ICICI Pru Technology Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G)

stock1

ICICI Pru Technology Fund - Direct (G)

3.31%

stock2

Nippon India Pharma Fund - Direct (G)

14.1%

Graph not available
Graph not available

About Fund

HDFC Bank Limited

Computer Age Management Services Pvt. Ltd.

Deutsche Bank AG

Karvy Computershare Pvt. Ltd.

Very High Risk

5000

14590.31

2.05

222.74

January 1, 2013

0

Very High Risk

5000

8569.15

1.12

582.4544

January 1, 2013

1

27.18 %

18.24 %

3.31 %

22.7 %

25.65 %

14.1 %

Manish Gunwani

B.Tech (Mechanical), PGDM

Overall 15 years of experience of which 8 years in equity research and one and half year in Fund management.

Mrinal Singh

BE (Mech), PGDM (SPJIMR - Mumbai)

He has an overall experience of around 16 years. He is associated with ICICI Prudential Asset Management Company Limited since June 2008. Past Experience: Wipro Ltd - IT Services - May 2005 to May 2008. BOSCH India (erstwhile MICO) - R&D - October 2000 to June 2003.

Sankaran Naren

B.Tech - IIT Madras, PGDM, IIM Calcutta

Prior to joining ICICI Prudential AMC, he has worked with various financial services companies like Refco Sify securities India Pvt. ltd., HDFC Securities Ltd. and Yoha Securities in Various Positions.

Vaibhav Dusad

MBA, B.Tech, M.Tech, IIT Chennai

Mr. Vaibhav Dusad has around 11 years of experience in field of investment analysis. Currently, he is a senior investment analyst and a fund manager Past Experience: Morgan Stanley - Research Analyst - June 2014 to December 2017. HSBC - Research Analyst - November 2011 to April 2013. Crisil Irevna - Research Analyst- October 2010 to October 2011. Zinnov - Research Analyst - October 2009 to September 2010.

Sailesh Raj Bhan

MBA (Finance), CFA.

Mr.Bhan is an MBA with specialization in Finance and CFA. Has over 9 Yrs. of experience in Equity Securities Research & Sequeir Investment Pvt. Ltd. for 5 years and with Emkay Share & stock Broker Pvt. Ltd. for 2 years.

Get your FAQs right

When comparing ICICI Pru Technology Fund - Direct (G) vs Nippon India Pharma Fund - Direct (G), consider factors such as historical performance, expense ratios, investment strategy, risk level, and the fund manager's credibility. Moreover, look at asset allocation and how each fund fits your investment goals.
Yes, you can invest in both ICICI Pru Technology Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) at the same time. This can help diversify your portfolio and balance risk, provided the fund manager's investment strategies streamline each other.
While comparing ICICI Pru Technology Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), the portfolio turnover ratio indicates how frequently assets within the fund are bought and sold. A high turnover may lead to higher transaction costs and tax implications, while a low turnover ratio indicates a buy-and-hold strategy.
Yes, you can typically switch between ICICI Pru Technology Fund - Direct (G) and Nippon India Pharma Fund - Direct (G), subject to the fund's policies and any applicable fees. It is important to consider potential tax implications and the timing of your switch.
Yes, you can compare ICICI Pru Technology Fund - Direct (G) and Nippon India Pharma Fund - Direct (G) based on their dividend payouts. Look at dividends profit, consistency, and growth, as these factors can influence your overall return on investment.

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions